Showing results (311-320 of 351) with videos related to

Sort By:
Pageof 36
Thrombosis Research|May 11, 2016
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational statusA Vignoli, S Tessarolo, M Marchetti, et al.
BMC Pregnancy and Childbirth|December 29, 2017
STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trialsA Pels, L C Kenny, Z Alfirevic, et al.
Haematologica|September 1, 1996
Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphomaT Lerede, R Bassan, A Rossi, et al.
Leukemia & Lymphoma|May 1, 1996
Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemiaA Rambaldi, V Attuati, R Bassan, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Role of early anthracycline dose-intensity according to expression of Philadelphia chromosome/BCR-ABL rearrangements in B-precursor adult acute lymphoblastic leukemiaR Bassan, A Z Rohatiner, T Lerede, et al.
Bone Marrow Transplantation|November 29, 2016
The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysisT Ruutu, A Gratwohl, D Niederwieser, et al.
Bone Marrow Transplantation|April 14, 2009
HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor RegistryR Crocchiolo, F Ciceri, K Fleischhauer, et al.
Health Technology Assessment (Winchester, England)|September 20, 2012
Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studiesJ Savović, He Jones, Dg Altman, et al.
Leukemia|July 20, 2007
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cellsJ Golay, L Cuppini, F Leoni, et al.
Leukemia|March 26, 2014
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphomaP Corradini, U Vitolo, A Rambaldi, et al.
Pageof 36